Delivery Order SPE2DR25D3009-SPE2DR26FWHY6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,142.89 to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 20, 2026, for the supply of Chloraseptic sore throat lozenges. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, is scheduled for completion by January 21, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for Chloraseptic Sore lozenges valued at $1,368.40 with a completion date of November 20, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $3,452.36 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 19, 2025, for Chloraseptic Sore 18s products. This firm fixed price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $1,250.55 to AmerisourceBergen Drug Corp for Chloraseptic Max 15-10 mg lozenges (15-pack units) on January 15, 2026, with an ultimate completion date of January 16, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a task order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for Chloraseptic Max 15-10 mg lozenges (15-count packages) with a ceiling value of $1,800.03 and a completion date of October 20, 2025. This is a firm fixed price, non-set-aside contract executed as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract represents routine pharmaceutical supply fulfillment to support...
- The Defense Logistics Agency awarded a $145 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count packages of Chloraseptic sore throat lozenges. The place of performance is Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order runs from July 10th through July 11th, 2023 under the parent company Amerisourcebergen Corporation's indefinite delivery vehicle with DLA. As a leading provider of pharmaceuticals and medical supplies,...
- The Defense Logistics Agency awarded a $314,790 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18-count packages of Chloraseptic sore throat lozenges. As part of DLA's medical supply chain support to the Department of Defense, this contract will provide sore throat relief medications to military treatment facilities from the contractor's distribution center in Conshohocken, Pennsylvania. Amerisourcebergen will fulfill the requirements as the prime contractor under this...
- The Defense Logistics Agency awarded a $802.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count bottles of Chloraseptic sore throat lozenges. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The order period of performance is July 31, 2023 through August 1, 2023. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen will fulfill this order to supply sore throat remedies for DLA's stockpile of...
- The Defense Logistics Agency awarded a $699.21 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count bottles of Chloraseptic sore throat lozenges. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a facility in Conshohocken, Pennsylvania by August 30, 2023 under the terms of the contract. The Defense Logistics Agency utilizes such contracts and delivery orders to efficiently procure medical supplies in...
- The Defense Logistics Agency awarded a $84 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 18 count packages of Chloraseptic sore throat lozenges. As the prime contractor, Amerisourcebergen will deliver the lozenges to a location in Conshohocken, Pennsylvania under a one day period of performance from July 10-11, 2023. The Defense Logistics Agency commonly issues delivery orders against various indefinite-delivery/indefinite-quantity multiple award contracts to...
- SPE2DR25D3009Indefinite Delivery Contract
- SPE2DR25D3009-SPE2DR26FWHY6Delivery Order
The Defense Logistics Agency awarded a $2,733.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for Chloraseptic Sore Throat Lozenges (18-count). The contract, which carries no set-aside designation, reflects a competitively awarded transaction under an indefinite delivery vehicle and is scheduled for completion by January 28, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s comprehensive $999,999,999 indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which extends through December 2031 and functions as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to military treatment facilities and federal healthcare programs globally. The contract structure exemplifies the company's role in fulfilling routine medical commodity needs alongside specialized pharmaceutical requirements, demonstrating its capability to efficiently support federal medical supply chains across multiple therapeutic domains and customer agencies including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 1/26/26 |